# Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/submission-of-documentation-in-applications-for-parametric-release-of-human-and-veterinary-drug-products-terminally-sterilized-by-moist-heat-processes-guidance-for-industry/5ca3ae22-e166-456b-bc1f-be17ce9ca044

> FDA guidance document: Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes:  Guidance for Industry. Issue date: February 26, 2010. Get complete insights and analysis.

---

## Details

- Title: Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2010-02-26
- Last Changed: 2022-04-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0391">FDA-2008-D-0391</a>

## Related Documents

- [Incorporation of  Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/incorporation-of-physical-chemical-identifiers-into-solid-oral-dosage-form-drug-products-for-anticounterfeiting-guidance-for-industry/aaf3882a-6876-4866-8763-fc1971c39742)
- [Residual Solvents in Drug Products Marketed in the United States:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/residual-solvents-in-drug-products-marketed-in-the-united-states-guidance-for-industry/2d91b105-6b2c-4231-bcff-63a0d7fdc832)
- [M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/m3r2-nonclinical-safety-studies-for-the-conduct-of-human-clinical-trials-and-marketing-authorization-for-pharmaceuticals/fab84a39-1f07-487f-ae13-2eb2b1884d18)
